Hyperandrogenism is the key pathologic feature of polycystic ovary syndrome, but diagnostic assessment of androgen excess in women is problematic, and the biochemical assays in routine clinical ...

Diamanti-Kandarakis E and Panidis D (2007) Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS. Clin Endocrinol (Oxf) 67: 735–742 The ...

Polycystic ovary syndrome (PCOS) is one of the most common hormonal and metabolic conditions in people with ovaries of reproductive age, affecting up to 10% of that population. It has a strong ...

Abbreviations: LDDST = low dose dexamethasone suppression test; LH = luteinizing hormone; PCOS = polycystic ovarian syndrome; UFC = urinary free cortisol. Clinical features initially attributed to ...

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age, affecting approximately 6% of this population. [1] The clinical issues in PCOS relate to ...

Polycystic ovary syndrome (PCOS) is a hormonal disorder commonly diagnosed in women of childbearing age. While PCOS isn’t an outwardly apparent condition, it can wreak havoc on physical and ...

ADPKD, or autosomal dominant polycystic kidney disease, can cause severe pain, headaches, and more problems. What can you do to feel better and stay active? Find exercise and diet tips ...

Polycystic ovary Syndrome (PCOS) may be one of the most common hormone conditions, but medical experts say that “hidden” symptoms are preventing as many as three in four from being diagnosed.

Discover top medications for 'treating Polycystic Ovarian Syndrome'? This page compiles essential information on generic and brand-name drugs specifically used for Polycystic Ovarian Syndrome ...

KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.